Rapha Capital Management
Overview
Rapha Capital Management is focused on identifying and growing revolutionary ideas in medicine, healthcare and technology before others can see their value . The firm focuses on strategic investments in early stage, non-public biotechnology companies .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Eos SENOLYTIX, Inc. | Feb 2025 | Series A | Lead |
| PrintBio, Inc. | Feb 2024 | Corporate Funding | Co-investor |
| ControlRad | Sep 2019 | Series B | Co-investor |
| Fize Medical | Sep 2026 | Series B | Lead |
| Demeetra AgBio | Apr 2021 | Convertible Debt | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Rapha Capital Management based?
Rapha Capital Management is headquartered in Surfside, Florida, United States.
When was Rapha Capital Management founded?
Rapha Capital Management was founded in 2018.
How many portfolio companies does Rapha Capital Management have?
Rapha Capital Management has 6 portfolio companies in Caplight's dataset.
What are some companies in Rapha Capital Management's portfolio?
Portfolio companies visible on Caplight include Eos SENOLYTIX, Inc., PrintBio, Inc., ControlRad, Fize Medical, Demeetra AgBio.
What was Rapha Capital Management's most recent investment shown here?
Rapha Capital Management's most recent investment in this portfolio sample was in Fize Medical in 2026.
What sectors does Rapha Capital Management focus on?
Rapha Capital Management focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Rapha Capital Management focus on?
Rapha Capital Management typically invests at the Early stage.
What is Rapha Capital Management's AUM?
Rapha Capital Management's assets under management are estimated between $50.0M and $100.0M.